SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 27 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $304,000 | -26.4% | 123,000 | 0.0% | 0.02% | -27.3% |
Q3 2014 | $413,000 | +25.5% | 123,000 | 0.0% | 0.02% | +22.2% |
Q2 2014 | $329,000 | +19.2% | 123,000 | 0.0% | 0.02% | +20.0% |
Q1 2014 | $276,000 | +14.0% | 123,000 | 0.0% | 0.02% | +15.4% |
Q4 2013 | $242,000 | – | 123,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 219,440,000 | $335,332,000 | 4.77% |
Sage Capital Management, LLC | 1,500,000 | $2,290,000 | 2.19% |
SYMPHONY ASSET MANAGEMENT LLC | 12,727,000 | $19,448,000 | 1.97% |
DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,200,000 | $1,840,000 | 0.77% |
Nicholas Investment Partners, LP | 5,000,000 | $7,641,000 | 0.64% |
AVIVA PLC | 25,000,000 | $38,328,000 | 0.34% |
PRUDENTIAL PLC | 38,326,000 | $58,566,000 | 0.15% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 8,000,000 | $12,225,000 | 0.13% |
FRANKLIN RESOURCES INC | 17,290,000 | $26,432,000 | 0.01% |
LORD, ABBETT & CO. LLC | 3,191,000 | $4,892,000 | 0.01% |